Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
Science Advances|August 26, 2021
Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammalsJoanne L Parker, Justin C Deme, Zhiyi Wu, et al.
Journal of Chemical Information and Modeling|May 25, 2023
Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity SearchStephanie Wills, Ruben Sanchez-Garcia, Tim Dudgeon, et al.
Molecular Pharmacology|June 16, 2010
Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptorsPatricio Iturriaga-Vásquez, Annalisa Carbone, Olimpo García-Beltrán, et al.
Journal of Chemical Information and Computer Sciences|November 24, 2004
Design and characterization of libraries of molecular fragments for use in NMR screening against protein targetsNicolas Baurin, Fareed Aboul-Ela, Xavier Barril, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2019
Muscle acetylcholine receptor conversion into chloride conductance at positive potentials by a single mutationHakan Cetin, Max Epstein, Wei W Liu, et al.
Toxicology Letters|January 22, 2021
Molecular determinants of binding of non-oxime bispyridinium nerve agent antidote compounds to the adult muscle nAChRMax Epstein, Karan Bali, Thomas J Piggot, et al.
Plos Computational Biology|April 12, 2014
rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acidsSergio Ruiz-Carmona, Daniel Alvarez-Garcia, Nicolas Foloppe, et al.
Molecular Pharmacology|March 15, 2008
A role for Leu118 of loop E in agonist binding to the alpha 7 nicotinic acetylcholine receptorShiva Amiri, Masaru Shimomura, Ranjit Vijayan, et al.
Drug Discovery Today|May 9, 2018
When fragments link: a bibliometric perspective on the development of fragment-based drug discoveryAngelo K S Romasanta, Peter van der Sijde, Iina Hellsten, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structuresBrian Dymock, Xavier Barril, Mandy Beswick, et al.
Pageof 23